about
P53 functional abnormality in mesenchymal stem cells promotes osteosarcoma developmentICAM1 Is a Potential Cancer Stem Cell Marker of Esophageal Squamous Cell CarcinomaAA-NAT, MT1 and MT2 Correlates with Cancer Stem-Like Cell Markers in Colorectal Cancer: Study of the Influence of Stage and p53 Status of TumorsSomatic loss of estrogen receptor beta and p53 synergize to induce breast tumorigenesis.p53 Family and Cellular Stress Responses in Cancer.Overshoot during phenotypic switching of cancer cell populationsHypoxic resistance of KRAS mutant tumor cells to 3-Bromopyruvate is counteracted by Prima-1 and reversed by N-acetylcysteine.Involvement of UTR-dependent gene expression in the maintenance of cancer stem cell like phenotypes.Clinical characterization for proliferation and metastasis in advanced hepatocellular carcinoma patients.Targeted Deletion of p53 in Lgr5-Expressing Intestinal Stem Cells Promotes Colon Tumorigenesis in a Preclinical Model of Colitis-Associated Cancer.The function of Drosophila p53 isoforms in apoptosis.Cerebellum Development and Tumorigenesis: A p53-Centric Perspective.β-Catenin C-terminal signals suppress p53 and are essential for artery formation.The paradigm of mutant p53-expressing cancer stem cells and drug resistance.p53 in liver pathologies-taking the good with the bad.Systematic meta-analyses and field synopsis of genetic association studies in colorectal adenomas.Transposable elements: Self-seekers of the germline, team-players of the soma.Oncogenic Mutant p53 Gain of Function Nourishes the Vicious Cycle of Tumor Development and Cancer Stem-Cell Formation.Downregulation of the Genes Involved in Reprogramming (SOX2, c-MYC, miR-302, miR-145, and P21) in Gastric Adenocarcinoma.Coculture of Preimplantation Embryos With Outgrowth Embryos Improves Embryonic Developmental Competence in Mice.Dissection of Regulatory Elements During Direct Conversion of Somatic Cells Into Neurons.Critical role for p53-serine 15 phosphorylation in stimulating transactivation at p53-responsive promoters.p53 on the crossroad between regeneration and cancer.Drug resistance and cancer stem cells: the shared but distinct roles of hypoxia-inducible factors HIF1α and HIF2α.Activation of p53/miR-34a Tumor Suppressor Axis by Chinese Herbal Formula JP-1 in A549 Lung Adenocarcinoma Cells.Differential regulated microRNA by wild type and mutant p53 in induced pluripotent stem cellsDysfunctional diversity of p53 proteins in adult acute myeloid leukemia: projections on diagnostic workup and therapy.Targeting deubiquitinating enzymes in cancer stem cells.Mutant p53 gain of function underlies high expression levels of colorectal cancer stem cells markers.Molecular mechanism of bystander effects and related abscopal/cohort effects in cancer therapy.Pleiotropic Role of p53 in Injury and Liver Regeneration after Acetaminophen Overdose.p53-dependent CD51 expression contributes to characteristics of cancer stem cells in prostate cancer.
P2860
Q26771603-A8EC8C79-3065-4D9E-9928-DD24547B7B86Q28550965-BFDE4579-4652-4971-979A-8F56ABEDBE30Q33838881-6822D66E-20BC-47D0-8483-D2119138C41DQ33864656-C7F92BA5-79F4-4417-99E3-57DD23B194F5Q34377287-21657AD6-B6B2-42DE-8A2A-F451221E2DADQ36192449-8D489259-967E-40D0-B890-22A100B3B5C2Q36198159-6CB7894B-6988-4B46-AAA4-196DED0C107DQ36336126-866CAC23-A43F-4F0A-86DF-34F8EF505C90Q36375510-9FA6F1D0-F3A3-476E-A901-83D46BB75A8DQ36378272-5E4F8B37-DCE5-463E-A329-14F4E5474CAAQ36751520-F52372F5-6FD1-4E99-B6D0-C05C3B889C13Q36860342-BD6B2984-C80D-41D2-863E-E2D7F80CFF7BQ37163437-465C58EC-8DB7-43D5-8173-25FA273A7D6EQ38198487-BB058DEE-0C7C-44E7-9A31-9705D6F548DCQ38268953-0CC6D50C-DC5C-4815-8D31-05C0AA793AACQ38602946-3BFEA09B-FE86-471E-BE9C-B9A48F9FF568Q38805744-8612624E-5222-4221-93E3-DD875E6912ADQ38846785-1FD90643-AACB-4895-83DC-E477AB6A283CQ38883315-EBD3E2FA-7E86-4B03-B97D-9D28D6BB2889Q38928059-5F842CDC-8505-4876-9573-7D3A4098B8F9Q38946546-14360E0C-C033-4F99-BA4A-E563756F6DE6Q38984847-F6B0337F-4CA2-4440-8825-77E3B6521229Q38987401-192B7B70-A267-4D20-8CC4-B9B57183E705Q38997399-F26AF29F-152A-4597-BAD2-1C5E6B099289Q40452377-CC9383C2-033B-485D-A13A-8F0F07AC6847Q41841045-3C1F979C-8767-416D-85B8-0482E116AF13Q44176860-ACDABF01-030A-4A08-9A0C-8E865F80ECEAQ44948244-B703BA8F-5657-406F-BEA8-4BEC99CD7EC3Q49988786-2B8268A0-E38B-4634-9B42-7AD9ABAC284FQ52714591-1BDEF5C5-E4E0-45B8-9DE4-4CF19CD3A193Q52719441-6450B596-6B7B-4FF5-B77D-F759120E6735Q53685182-CF8CCB0B-380B-4F39-B1E9-3AE66136D21F
P2860
description
2014 nî lūn-bûn
@nan
2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
p53: the barrier to cancer stem cell formation.
@ast
p53: the barrier to cancer stem cell formation.
@en
p53: the barrier to cancer stem cell formation.
@nl
type
label
p53: the barrier to cancer stem cell formation.
@ast
p53: the barrier to cancer stem cell formation.
@en
p53: the barrier to cancer stem cell formation.
@nl
prefLabel
p53: the barrier to cancer stem cell formation.
@ast
p53: the barrier to cancer stem cell formation.
@en
p53: the barrier to cancer stem cell formation.
@nl
P2093
P2860
P1433
P1476
p53: the barrier to cancer stem cell formation.
@en
P2093
Ronit Aloni-Grinstein
Tom Kaufman
Varda Rotter
Yoav Shetzer
P2860
P304
P356
10.1016/J.FEBSLET.2014.02.011
P407
P577
2014-02-19T00:00:00Z